146 related articles for article (PubMed ID: 10787411)
1. Specific recognition of androgens by their nuclear receptor. A structure-function study.
Poujol N; Wurtz JM; Tahiri B; Lumbroso S; Nicolas JC; Moras D; Sultan C
J Biol Chem; 2000 Aug; 275(31):24022-31. PubMed ID: 10787411
[TBL] [Abstract][Full Text] [Related]
2. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Berrevoets CA; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406
[TBL] [Abstract][Full Text] [Related]
4. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A
Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464
[TBL] [Abstract][Full Text] [Related]
5. Co-activator and co-repressor interplay on the human androgen receptor.
Papaioannou M; Reeb C; Asim M; Dotzlaw H; Baniahmad A
Andrologia; 2005 Dec; 37(6):211-2. PubMed ID: 16336251
[No Abstract] [Full Text] [Related]
6. Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens.
Terouanne B; Nirdé P; Rabenoelina F; Bourguet W; Sultan C; Auzou G
Mol Pharmacol; 2003 Apr; 63(4):791-8. PubMed ID: 12644579
[TBL] [Abstract][Full Text] [Related]
7. Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei.
Karvonen U; Jänne OA; Palvimo JJ
FEBS Lett; 2002 Jul; 523(1-3):43-7. PubMed ID: 12123801
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogens prevent stable DNA-binding of the androgen receptor.
Farla P; Hersmus R; Trapman J; Houtsmuller AB
J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of androgen receptor protein is induced by agonist, not by antagonists.
Furutani T; Watanabe T; Tanimoto K; Hashimoto T; Koutoku H; Kudoh M; Shimizu Y; Kato S; Shikama H
Biochem Biophys Res Commun; 2002 Jun; 294(4):779-84. PubMed ID: 12061774
[TBL] [Abstract][Full Text] [Related]
10. Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Klokk TI; Kurys P; Elbi C; Nagaich AK; Hendarwanto A; Slagsvold T; Chang CY; Hager GL; Saatcioglu F
Mol Cell Biol; 2007 Mar; 27(5):1823-43. PubMed ID: 17189428
[TBL] [Abstract][Full Text] [Related]
11. Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.
Brooke GN; Gamble SC; Hough MA; Begum S; Dart DA; Odontiadis M; Powell SM; Fioretti FM; Bryan RA; Waxman J; Wait R; Bevan CL
Mol Cell Proteomics; 2015 May; 14(5):1201-16. PubMed ID: 25693800
[TBL] [Abstract][Full Text] [Related]
12. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor.
Azhagiya Singam ER; Tachachartvanich P; La Merrill MA; Smith MT; Durkin KA
J Phys Chem B; 2019 Sep; 123(36):7657-7666. PubMed ID: 31431014
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression.
Fuse H; Korenaga S; Sakari M; Hiyama T; Ito T; Kimura K; Kato S
Prostate; 2007 May; 67(6):630-7. PubMed ID: 17342748
[TBL] [Abstract][Full Text] [Related]
14. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
[TBL] [Abstract][Full Text] [Related]
15. Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities.
Vivat V; Gofflo D; Garcia T; Wurtz JM; Bourguet W; Philibert D; Gronemeyer H
J Mol Endocrinol; 1997 Apr; 18(2):147-60. PubMed ID: 9134501
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
Wang LG; Liu XM; Kreis W; Budman DR
Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909
[TBL] [Abstract][Full Text] [Related]
17. Conformational dynamics of androgen receptors bound to agonists and antagonists.
Gim HJ; Park J; Jung ME; Houk KN
Sci Rep; 2021 Aug; 11(1):15887. PubMed ID: 34354111
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK
Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541
[TBL] [Abstract][Full Text] [Related]
19. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
20. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]